trans-Trimethoxyresveratrol, CAS [[22255-22-7]]

Produktübersicht

• Artikelname: trans-Trimethoxyresveratrol, CAS [[22255-22-7]]
• Artikelnummer: MCE-HY-N1408
• Hersteller Artikelnummer: HY-N1408
• Alternativnummer: MCE-HY-N1408-100MG,MCE-HY-N1408-50MG,MCE-HY-N1408-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: trans-trismethoxy Resveratrol, (E)-Resveratrol trimethyl ether, trans-3,5,4-Trimethoxystilbene

Produktbeschreibung

Trans-Trimethoxyresveratrol (trans-trismethoxy Resveratrol, (E)-Resveratrol trimethyl ether, trans-3,5,4-Trimethoxystilbene) is an orally active natural derivative of Resveratrol (HY-16561). Trans-Trimethoxyresveratrol has an enhanced anticancer profile compared to Resveratrol, exhibiting higher potency than resveratrol, with improved cancer cell proliferation inhibition, induction of cell cycle arrest, decreased metastasis, and increased apoptosis. Trans-Trimethoxyresveratrol causes microtubule disassembling and tubulin depolymerization and exerts anti-angiogenic effects through VEGFR2. Trans-Trimethoxyresveratrol can be used for the studies of anti-angiogenic and anti-cancer (such as non-small cell lung cancer and osteosarcoma)[1][2][3][4][5][6].

Produkteigenschaften

• Molekulargewicht: 270.32
• Reinheit: 99.35
• CAS Nummer: [22255-22-7]
• Formel: C17H18O3
• Target-Kategorie: Apoptosis,Caspase,Reactive Oxygen Species (ROS),VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Natural Products